A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older
Clinical trial NCT07489183 · COMPLETED
Trial details
- NCT number
- NCT07489183
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-23
- Primary completion
- 2023-09-07
- Enrollment
- 641
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.